Dornase alfa

Dornase alfa
Clinical data
Trade names	Pulmozyme
AHFS/Drugs.com	Monograph
MedlinePlus	a694002
License data	US DailyMed: Dornase alfa;
Pregnancy; category	AU: B1;
Routes of; administration	Inhalation
ATC code	R05CB13 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: ℞-only / Schedule D; US: ℞-only; In general: ℞ (Prescription only);
Identifiers
CAS Number	143831-71-4 ;
DrugBank	DB00003 ;
ChemSpider	none;
UNII	953A26OA1Y;
KEGG	D03896;
CompTox Dashboard (EPA)	DTXSID801010888 ;
ECHA InfoCard	100.029.685
Chemical and physical data
Formula	C1321H1999N339O396S9
Molar mass	29254.04 g·mol−1
	(what is this?) (verify)

Dornase alfa, sold under the brand name Pulmozyme, is used for the treatment of cystic fibrosis. It is a recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA. Dornase alfa hydrolyzes the DNA present in sputum/mucus and reduces viscosity in the lungs, promoting improved clearance of secretions. It is produced in Chinese hamster ovary cells.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.